Migraine Prevention Medications May Cause Adverse Pharmacological Side Effects

Over 30 million Americans suffer from debilitating migraines. Pharmaceutical preventative options may be accompanied by side effects such as nausea and vomiting. Many sufferers are seeking safe and effective non-pharmaceutical prevention options.
 
 
The Headache Remedy
The Headache Remedy
 
Spread the Word
Listed Under

Tags:
Migraine
Migraine Prevention
Headaches
Nti
Tmj Pain
Tmj
Tension
Cluster Headaches
Fda Approved
Treatment
Pain

Industrys:
Medical
Health
Lifestyle

Location:
Missouri - US

Dec. 2, 2009 - PRLog -- More than 30 million Americans suffer from migraines. The pain and discomfort can range from mild discomfort to debilitating pain accompanied by light sensitivity and nausea. Unfortunately, there is a common misconception that migraine is simply a bad headache. This lack of education leads to many patients not seeking treatment and many patients are unaware of the prevention and treatment options available. A 1998 study co-authored by Richard Lipton, M.D. noted that US businesses lose over $13 billion per year due to migraine related expenses.

For those that do seek the help of medical professionals, pharmaceutical preventative and therapeutic options are most often prescribed. These medications can be effective but are often accompanied by side effects including nausea, vomiting, and rebound headaches. These side effects can be as debilitating as the migraines they are used to prevent, resulting in loss of work productivity. A 1998 study co-authored by Richard Lipton, M.D. noted that US businesses lose over $13 billion per year due to migraine related expenses.

There are migraine prevention alternatives, including the avoidance of migraine triggers. These triggers may be certain odors or foods. One option that has proven to be effective is an FDA approved biteguard called the NTI-tss Plus. It fits over the front four teeth, making it easy to wear while sleeping. It's patented design keeps the canine and back teeth separated, reducing nighttime clenching intensity, a major catalyst for migraine and tension-type headaches. In a clinical trial reviewed by the FDA, 82% of NTI-tss users experienced a 77% reduction in migraine events, with no pharmacological side effects.

To find more about the NTI-tss Plus, visit www.TheHeadacheRemedy.com

# # #

There are over 30 million migraine sufferers in the US. The NTI-tss Plus is a small biteguard, FDA approved for the prevention of migraines, tension-type headaches, and TMJ dysfunction with no pharmacological side effects.
End
Source:The Headache Remedy
Email:***@kellerlab.com Email Verified
Phone:636-600-4260
Zip:63026
Account Email Address Verified     Disclaimer     Report Abuse
Keller Laboratories PRs
Trending News
Top Daily News
Top Weekly News



Like PRLog?
9K2K1K
Click to Share